R01: Preclinical drug repurposing & combination therapies for Alzheimer’s (clinical trials not allowed)
This R01 funds rigorous preclinical proof-of-concept testing of drug candidates and drug combinations identified by data-driven/translational bioinformatics for treatment or prevention of Alzheimer’s disease and related dementias. Projects should use mouse or cell-based models (e.g., iPSCs, organoids), follow NIH rigor and ARRIVE guidelines, prioritize candidates (including failed Phase II/III…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers